Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeffery W. Clark"'
Autor:
Nikhil Khushalani, David Gerber, Jeffery W. Clark, Wells Messersmith, Tricia Heinrichs, Nicole Zion, Jordan Berlin
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:QIM22-197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b07fde2eab4154dca9b47cf81c4f6b5e
https://doi.org/10.6004/jnccn.2021.7226
https://doi.org/10.6004/jnccn.2021.7226
Autor:
Kim O. Gococo, Jeffery W. Clark, Carl G. Kardinal, Ramesh K. Ramanathan, Edith P. Mitchell, D. G. Haller, Heinz-Josef Lenz, Nancy E. Kemeny
Publikováno v:
Journal of Clinical Oncology. 21:2904-2911
Purpose: Two consecutive compassionate use studies of oxaliplatin were conducted in the United States and Canada in more than 5,000 patients with locally advanced or metastatic colorectal carcinoma who had experienced treatment failure after at least
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::affb47cc92f3e43d36c4f7914480720d
https://doi.org/10.1200/jco.2003.11.045
https://doi.org/10.1200/jco.2003.11.045
Autor:
Eric K. Rowinsky, Patrick J. Loehrer, Charles D. Blanke, Joel Picus, Donald E. Thornton, William John, Jeffery W. Clark, Lawrence N. Schulman
Publikováno v:
Cancer. 88:1807-1813
BACKGROUND The aim of this study was to confirm the activity and assess the safety profile of multitargeted antifolate (MTA) for patients with metastatic colorectal adenocarcinoma. METHODS Forty-six patients were enrolled in the study, 35 with colon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc69c82db0cae55c826e96b6e891acee
https://doi.org/10.1002/(sici)1097-0142(20000415)88:8<1807::aid-cncr8>3.0.co
https://doi.org/10.1002/(sici)1097-0142(20000415)88:8<1807::aid-cncr8>3.0.co
Autor:
Gregory Curt, Michael C. Wiemann, Frank J. Cummings, Susan Urba, Christopher A. Slapak, Paul Calabresi, Nicholas J. Robert, Alan B. Weitberg, Marcia J. Browne, Jeffery W. Clark, Marshall R. Posner
Publikováno v:
American Journal of Clinical Oncology. 13:455-458
Twenty-nine evaluable patients with colorectal adenocarcinoma were treated in a phase I-II trial of combination chemotherapy with a 72-h continuous infusion of cisplatin (CDDP) and 5-fluorouracil (5-FU) with an infusion of VP-16 given at 24 and 48 h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204c28e54853da85d8919ab896e6e7e4
https://doi.org/10.1097/00000421-199010000-00019
https://doi.org/10.1097/00000421-199010000-00019
Autor:
Paul Calabresi, Alan B. Weitberg, Isa Brunetti, Marshall R. Posner, Julie Beitz, James W. Darnowski, Marcia J. Browne, Jeffery W. Clark, Gregory Curt, Donna Corvese, Frank J. Cummings
Publikováno v:
Journal of the National Cancer Institute. 82(21)
A phase I clinical, pharmacologic, and biochemical evaluation of escalating oral zidovudine (AZT) given over 2 days with a fixed dose of continuous-infusion fluorouracil (800 mg/m2 per day X 3 days) and oral leucovorin calcium was performed. Eighteen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3604c89f9f731c4dcb778d2a2d6a43e
https://pubmed.ncbi.nlm.nih.gov/2231760
https://pubmed.ncbi.nlm.nih.gov/2231760